UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The cholinergic system and spatial learning

Behavioural brain research, 2011-08, Vol.221 (2), p.389-411

2011

Volltextzugriff (PDF)

Sustained MK-801 induced deficit in a novel probabilistic reversal learning task

Frontiers in pharmacology, 2022-10, Vol.13, p.898548-898548

2022

Volltextzugriff (PDF)

Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models

Behavioural pharmacology, 2015-06, Vol.26 (4), p.353-368

2015

Volltextzugriff (PDF)

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?

Drug testing and analysis, 2013-01, Vol.5 (1), p.46-51

Deiana, Serena

2013

Volltextzugriff (PDF)

Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents

European journal of pharmacology, 2022-11, Vol.935, p.175306-175306, Article 175306

2022

Volltextzugriff (PDF)

An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives

Brain Research Reviews, 2007-01, Vol.53 (1), p.1-16

2007

Volltextzugriff (PDF)

Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase‐1 improves cognitive performance

British journal of pharmacology, 2018-07, Vol.175 (14), p.3021-3033

2018

Volltextzugriff (PDF)

Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction

Neuropharmacology, 2024-08, Vol.254, p.109970, Article 109970

2024

Volltextzugriff (PDF)

Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions

Neuropharmacology, 2022-08, Vol.213, p.109078-109078, Article 109078

2022

Volltextzugriff (PDF)

MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol

Behavioural pharmacology, 2015-12, Vol.26 (8 Spec No), p.748-765

2015

Volltextzugriff (PDF)

Targeting the dopamine D 1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance

British journal of pharmacology, 2018-07, Vol.175 (14), p.3021-3033

2018

Volltextzugriff (PDF)

Reactivity to conditioned threat cues is distinct from exploratory drive in the elevated plus maze

The European journal of neuroscience, 2023-01, Vol.57 (1), p.54-63

2023

Volltextzugriff (PDF)

Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine

Psychopharmacology, 2009, Vol.202 (1-3), p.53-65

2009

Volltextzugriff (PDF)

PM537. GPR52 agonists show pro-cognitive properties

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.95-95

2016

Volltextzugriff (PDF)

The cholinergic system and spatial learning: The cholinergic system and brain function

Behavioural brain research, 2011, Vol.221 (2), p.389-411

2011

Volltextzugriff (PDF)

Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats

Neuropharmacology, 2007-02, Vol.52 (2), p.646-654

2007

Volltextzugriff (PDF)

Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats

Neuropharmacology, 2005-06, Vol.48 (8), p.1097-1104

2005

Volltextzugriff (PDF)

Endocannabinoid system and opioid addiction: Behavioural aspects

Pharmacology, biochemistry and behavior, 2005-06, Vol.81 (2), p.343-359

2005

Volltextzugriff (PDF)

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat

British journal of pharmacology, 2004-10, Vol.143 (3), p.343-350

2004

Volltextzugriff (PDF)

Methylthioninium chloride reverses cognitive deficits induced by scopolamine : comparison with rivastigmine: Special Issue on Cognitive Enhancers

Psychopharmacologia, 2009, Vol.202 (1-3), p.53-65

2009

Volltextzugriff (PDF)

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta super(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Psychopharmacology, 2012-02, Vol.219 (3), p.859-873

2012

Volltextzugriff (PDF)

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), [Delta]^sup 9^-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Psychopharmacology, 2012-02, Vol.219 (3), p.859

2012

Volltextzugriff (PDF)

Plasma and brain pharmacokinetic profile of cannabidiol in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Psychopharmacology, 2012-02, Vol.219 (3), p.859

2012

Volltextzugriff (PDF)

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

Psychopharmacologia, 2012-02, Vol.219 (3), p.859-873

2012

Volltextzugriff (PDF)

P2-428: Methylthioninium chloride versus rivastigmine and their co-administration efficacy in reversing scopolamine-induced cognitive deficits in a pharmacological mouse model of Alzheimer's disease

Alzheimer's & dementia, 2008-07, Vol.4 (4), p.T499-T499

2008

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(48)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(22)
Neurosciences
(17)
Animals
(15)
Neurosciences & Neurology
(15)
Pharmacology & Pharmacy
(14)
Humans
(12)
Male
(10)
Biological And Medical Sciences
(8)
Female
(6)
Medical Sciences
(6)
Self Administration
(6)
Behavioral Sciences
(5)
Mice
(5)
Neurology
(5)
Psychiatry
(5)
Psychology. Psychoanalysis. Psychiatry
(5)
Rats
(5)
Relapse
(5)
Schizophrenia
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The cholinergic system and spatial learning

Sustained MK-801 induced deficit in a novel probabilistic reversal learning task

Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models

Medical use of cannabis. Cannabidiol: A new light for schizophrenia?

Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents

An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives

Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase‐1 improves cognitive performance

Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction

Effects of GPR139 agonism on effort expenditure for food reward in rodent models: Evidence for pro-motivational actions

MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol

Targeting the dopamine D 1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance

Reactivity to conditioned threat cues is distinct from exploratory drive in the elevated plus maze

Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine

PM537. GPR52 agonists show pro-cognitive properties

The cholinergic system and spatial learning: The cholinergic system and brain function

Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats

Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats

Endocannabinoid system and opioid addiction: Behavioural aspects

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid‐seeking behaviour in the rat

Methylthioninium chloride reverses cognitive deficits induced by scopolamine : comparison with rivastigmine: Special Issue on Cognitive Enhancers

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Delta super(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), [Delta]^sup 9^-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Plasma and brain pharmacokinetic profile of cannabidiol in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

P2-428: Methylthioninium chloride versus rivastigmine and their co-administration efficacy in reversing scopolamine-induced cognitive deficits in a pharmacological mouse model of Alzheimer's disease

Suchergebnisse filtern